FDA.reportPublic FDA data

LUBIPROSTONE

Substance profile for UNII 7662KG2R6K, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for LUBIPROSTONE
Structure render from PubChem CID 157920

Substance Identity#

UNII
7662KG2R6K
Preferred term
LUBIPROSTONE
Registry number
136790-76-6
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C20H32F2O5
Chemical structure for LUBIPROSTONE
Structure render from PubChem CID 157920

Chemical And Database Identifiers#

InChIKey
WGFOBBZOWHGYQH-MXHNKVEKSA-N
SMILES
CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(O)=O)O1
RxCUI
623033
PubChem
157920
NCIt
C66040
INN ID
8254

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound157920pubchem.ncbi.nlm.nih.gov/compound/157920
PubChem InChIKey SearchWGFOBBZOWHGYQH-MXHNKVEKSA-Npubchem.ncbi.nlm.nih.gov/#query=WGFOBBZOWHGYQH-MXHNKVEKSA-N
RxNorm623033mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=623033
NCI ThesaurusC66040ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C66040
FDA Substance Registration System7662KG2R6Kprecision.fda.gov/uniisearch/srs/unii/7662KG2R6K

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYThese highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsules, for oral use Initial U.S. Approval: 20062
ACTIVE INGREDIENTThese highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsules, for oral use Initial U.S. Approval: 20062
ACTIVE INGREDIENTThese highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 20061
ACTIVE MOIETYThese highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 20061
ACTIVE INGREDIENTThese highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 20063
ACTIVE MOIETYThese highlights do not include all the information needed to use AMITIZA safely and effectively. See full prescribing information for AMITIZA. AMITIZA (lubiprostone) capsule, gelatin coated for oral use Initial U.S. Approval: 20063
ACTIVE INGREDIENTAMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3170
ACTIVE MOIETYAMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3170
ACTIVE MOIETYAMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.]10
ACTIVE INGREDIENTAMITIZA (LUBIPROSTONE) CAPSULE, GELATIN COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.]10